Advanced Prostate Cancer Drug May Help at Earlier Stage

WEDNESDAY, May 16 (HealthDay News) -- A drug approved to treat advanced prostate cancer appears to help men who have localized high-risk prostate cancer if given before surgery.

Prostate Cancer? Why Radical Surgery/Robotic Prostatectomy is NOT For You

CORAL SPRINGS, Fla., May 17, 2012 /PRNewswire/ -- As the world's top urologists begin the 107th Annual AUA Meeting in Atlanta this Friday, one of the nation's top prostate cancer specialists is challenging ...

J&J drug shows promise in high-risk prostate cancer

Adding Johnson & Johnson's advanced prostate cancer drug, Zytiga, to hormone therapy before surgery has been shown for the first time to eradicate tumors in some men with high-risk forms of the disease. ...

Press Release

Prostate Cancer? Why Radical Surgery/Robotic Prostatectomy is NOT For You SEITZ INC. Posted on:17 May 12

J&J’s Zytiga Helps Eliminate Early-Stage Prostate Cancer

Johnson & Johnson (JNJ) ’s Zytiga, approved last year to treat metastatic prostate cancer, helped eliminate tumors in high-risk patients whose malignancy hadn’t yet spread beyond the prostate gland, a small study found.